Haifeng Xu
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 27
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis 11
- Pancreatic and Hepatic Oncology Research 8
- Ophthalmology top 5%
- Retinal Diseases and Treatments 5
- Surgery top 10%
- Cholangiocarcinoma and Gallbladder Cancer Studies 28
-
- Liver Disease Diagnosis and Treatment 8
-
- Cancer Mechanisms and Therapy 6
-
- Gastric Cancer Management and Outcomes 5
- Cited by
- HepatologyOncologyOphthalmology
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Haifeng Xu
74 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 91
- Hepatology 322
- Oncology 410
- Ophthalmology 95
- Cancer Research 142
- Surgery 294
Countries citing papers authored by Haifeng Xu
This map shows the geographic impact of Haifeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haifeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haifeng Xu more than expected).
Fields of papers citing papers by Haifeng Xu
This network shows the impact of papers produced by Haifeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haifeng Xu. The network helps show where Haifeng Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haifeng Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 7 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 20 | |
| 10 | 2021 | 37 | |
| 11 | 2020 | 6 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 21 | |
| 14 | 2020 | 4 | |
| 15 | 2019 | 103 | |
| 16 | 2019 | 4 | |
| 17 | 2019 | 4 | |
| 18 | 2017 | 84 | |
| 19 | 2013 | 5 | |
| 20 | 2012 | 7 |
About Haifeng Xu
Haifeng Xu is a scholar working on Hepatology, Oncology and Surgery, having authored 75 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (28 papers), Hepatocellular Carcinoma Treatment and Prognosis (27 papers), Inflammatory Biomarkers in Disease Prognosis (11 papers), Pancreatic and Hepatic Oncology Research (8 papers), Liver Disease Diagnosis and Treatment (8 papers), Cancer Mechanisms and Therapy (6 papers), Retinal Diseases and Treatments (5 papers) and Gastric Cancer Management and Outcomes (5 papers). The work is most often cited by research in Hepatology (322 citations), Oncology (410 citations) and Ophthalmology (95 citations). Haifeng Xu has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Yilei Mao, Xinting Sang, Haitao Zhao, Huayu Yang, Shunda Du, Shouxian Zhong, Lejia Sun, Yiyao Xu, Xin Lu and Fanxing Zeng.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.